DRTS
Price
$14.43
Change
-$0.01 (-0.07%)
Updated
Sep 11 closing price
Capitalization
1.33B
73 days until earnings call
Intraday BUY SELL Signals
RXRX
Price
$3.20
Change
+$0.04 (+1.27%)
Updated
Sep 11 closing price
Capitalization
1.73B
60 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

DRTS vs RXRX

DRTS vs RXRX Comparison Chart in %
View a ticker or compare two or three
VS
DRTS vs. RXRX commentary
Sep 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DRTS is a Hold and RXRX is a Hold.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RXRX($1.73B) has a higher market cap than DRTS($1.33B). DRTS YTD gains are higher at: 191.515 vs. RXRX (-21.760). DRTS has higher annual earnings (EBITDA): -90.37M vs. RXRX (-443.62M). RXRX has more cash in the bank: 546M vs. DRTS (101M). DRTS has less debt than RXRX: DRTS (15.2M) vs RXRX (66.6M). RXRX has higher revenues than DRTS: RXRX (53.9M) vs DRTS (0).
DRTSRXRXDRTS / RXRX
Capitalization1.33B1.73B77%
EBITDA-90.37M-443.62M20%
Gain YTD191.515-21.760-880%
P/E RatioN/AN/A-
Revenue053.9M-
Total Cash101M546M18%
Total Debt15.2M66.6M23%
TECHNICAL ANALYSIS
Technical Analysis
DRTSRXRX
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
77%
Bullish Trend 2 days ago
80%
Momentum
ODDS (%)
Bearish Trend 2 days ago
69%
Bearish Trend 2 days ago
84%
MACD
ODDS (%)
Bearish Trend 2 days ago
78%
Bearish Trend 2 days ago
88%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
76%
Bearish Trend 2 days ago
87%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
86%
Advances
ODDS (%)
Bullish Trend 9 days ago
77%
Bullish Trend 9 days ago
83%
Declines
ODDS (%)
Bearish Trend 4 days ago
75%
Bearish Trend 3 days ago
87%
BollingerBands
ODDS (%)
N/A
Bearish Trend 2 days ago
89%
Aroon
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
85%
COMPARISON
Comparison
Sep 12, 2026
Stock price -- (DRTS: $14.43 vs. RXRX: $3.20)
Brand notoriety: DRTS and RXRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DRTS: 70% vs. RXRX: 44%
Market capitalization -- DRTS: $1.33B vs. RXRX: $1.73B
DRTS [@Biotechnology] is valued at $1.33B. RXRX’s [@Biotechnology] market capitalization is $1.73B. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $130.64B. The average market capitalization across the [@Biotechnology] industry is $2.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DRTS’s FA Score shows that 0 FA rating(s) are green while RXRX’s FA Score has 1 green FA rating(s).

  • DRTS’s FA Score: 0 green, 5 red.
  • RXRX’s FA Score: 1 green, 4 red.
According to our system of comparison, RXRX is a better buy in the long-term than DRTS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DRTS’s TA Score shows that 2 TA indicator(s) are bullish while RXRX’s TA Score has 4 bullish TA indicator(s).

  • DRTS’s TA Score: 2 bullish, 4 bearish.
  • RXRX’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, RXRX is a better buy in the short-term than DRTS.

Price Growth

DRTS (@Biotechnology) experienced а -3.99% price change this week, while RXRX (@Biotechnology) price change was -11.85% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.09%. For the same industry, the average monthly price growth was -3.45%, and the average quarterly price growth was +2531.70%.

Reported Earning Dates

DRTS is expected to report earnings on Nov 24, 2026.

RXRX is expected to report earnings on Nov 11, 2026.

Industries' Descriptions

@Biotechnology (-6.09% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
DRTS
Daily Signal:
Gain/Loss:
RXRX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
IBLC47.231.00
+2.17%
iShares Blockchain and Tech ETF
AGD11.960.14
+1.18%
abrdn Global Dynamic Dividend Fund
FINT36.900.32
+0.89%
Frontier Asset Total International Equity ETF
FFLV28.780.24
+0.86%
Fidelity Fundamental Large Cap Value ETF
NVDY12.370.02
+0.16%
YieldMax NVDA Option Income Strategy ETF

DRTS and

Correlation & Price change

A.I.dvisor indicates that over the last year, DRTS has been loosely correlated with ORMP. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if DRTS jumps, then ORMP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DRTS
1D Price
Change %
DRTS100%
-0.07%
ORMP - DRTS
49%
Loosely correlated
-2.10%
FDMT - DRTS
27%
Poorly correlated
-2.37%
TNXP - DRTS
27%
Poorly correlated
-3.34%
IBIO - DRTS
27%
Poorly correlated
-1.63%
RXRX - DRTS
26%
Poorly correlated
+1.27%
More